NPI registry status
Active
2026 NPPES data Neuroscience Registered Nurse NPI 1720091556 NP
Verify on CMS → Marijean Buhse, NP
Neuroscience Registered Nurse in East Meadow, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 297 in Neuroscience Registered Nurse, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
517
Medicare Part D claims · 93 beneficiaries · Neuroscience Registered Nurse avg: 1K
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
84.5/100
▲ 1 pts above national avg 83.1 · Above neutral
Industry payments
$13.9K
50 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Marijean Buhse, NP reported a CMS MIPS final score of 84.5/100 - above the 83.1 national average - and filed 517 Medicare Part D claims in 2023.
- 84.5/100
- MIPS score · +1 vs avg
- 517
- Part D claims, 2023
- 85%
- generic prescribing
- $13.9K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Marijean Buhse, NP's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
85 45th percentile higher than 45% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Marijean Buhse, NP sits
This provider among neuroscience registered nurse peers
Across the 16 neuroscience registered nurse providers who report both Medicare Part D prescribing and a MIPS quality score, Marijean Buhse, NP writes more Part D claims than 63% of them and scores higher on MIPS quality than 31% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one neuroscience registered nurse peer from a representative sample of 15; the gold marker is Marijean Buhse, NP. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Marijean Buhse, NP?
Near national averagePrimary specialty
Neuroscience Registered Nurse
Medicare Part D claims
517 49% vs specialty avg
MIPS final score
84.5/100 1.4 pts vs avg
Specialty distribution in New York
How Neuroscience Registered Nurse compares to other specialties among New York providers
Medicare quality performance, MIPS
Marijean Buhse, NP's 2023 MIPS final score plotted against the Neuroscience Registered Nurse national average
- MIPS Final Score
- 84.5/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Neuroscience Registered Nurse) - 84.5/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Marijean Buhse, NP appears in the CMS NPPES registry as a Neuroscience Registered Nurse provider holding NP credentials at 801 MERRICK AVE, East Meadow, NY, 11554, with a listed phone of (516) 393-8936. NPI 1720091556 was issued on 08/14/2006.
Medicare Part D records for calendar year 2023 show 517 prescription claims written by this provider, covering 93 Medicare beneficiaries and totaling roughly $878K in drug spend, split 15% brand-name and 85% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84.5/100 for the 2023 performance year (Quality 93.3, Cost 54.9), compared with the national average of 83.1.
Neuroscience Registered Nurse is a narrow specialty nationwide, with 297 enrolled providers across 43 states and an average of 1,016 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1720091556 |
|---|---|
| Specialty | Neuroscience Registered Nurse |
| Credentials | NP |
| Gender | Female |
| NPI Issued | 08/14/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
84.4744
Final Score
Avg: 83.1
93.334
Quality
54.914
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Marijean Buhse, NP bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
New York University
New York, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Marijean Buhse, NP. Source: openpaymentsdata.cms.gov.
Total received
$13.9K
Largest payer
Biogen, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Marijean Buhse, NP. To verify Marijean Buhse, NP's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Marijean Buhse, NP - brand share 15.0%
Neuroscience Registered Nurse average
15% brand-name claims vs 85% generic, on 517 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
517
Total Claims
$878K
Total Drug Cost
93
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 860
- Total Day Supply
- 25,349
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $835K
- Generic Drug Cost
- $43K
Patient Demographics
- Average Patient Age
- 64.4 years
- Avg HCC Risk Score
- 1.42
- Gender Split
- 70% female / 30% male
- Age Distribution
- <65: 40, 65-74: 36, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Marijean Buhse, NP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Baclofen
Baclofen
38 claims
- Gabapentin
Gabapentin
37 claims
- Tizanidine Hcl
Tizanidine Hcl
26 claims
- Topiramate
Topiramate
25 claims
- Bupropion Xl
Bupropion Xl
24 claims
- Dalfampridine Er
Dalfampridine Er
20 claims
- Duloxetine Hcl
Duloxetine Hcl
20 claims
- Sertraline Hcl
Sertraline Hcl
19 claims
| Drug | Claims |
|---|---|
| Baclofen | 38 |
| Gabapentin | 37 |
| Tizanidine Hcl | 26 |
| Topiramate | 25 |
| Bupropion Xl Bupropion Hcl | 24 |
| Dalfampridine Er Dalfampridine | 20 |
| Duloxetine Hcl | 20 |
| Sertraline Hcl | 19 |
| Sumatriptan Succinate | 19 |
| Mayzent Siponimod | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neuroscience Registered Nurse Overview
How Marijean Buhse, NP fits within the Neuroscience Registered Nurse landscape nationally.
297
Neuroscience Registered Nurse Providers in US
43
States with Neuroscience Registered Nurse
1,016
Avg Claims per Provider
Marijean Buhse, NP's 517 claims are below the specialty average of 1,016.
Nearby Neuroscience Registered Nurse Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Buhse.
Dr. Meagan Aladin
NP
New York, NY
Dr. Bernice Burford
NP
New York, NY
Dr. Catherine Chu
RN, NP
Syracuse, NY
Dr. Erica Cottet
REGISTERED NURSE
Fulton, NY
Dr. Margaret Cox
NP
Great Neck, NY
Compare Neuroscience Registered Nurse nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Neuroscience Registered Nurse peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Marijean Buhse, NP's specialty? ▼
Marijean Buhse, NP specializes in Neuroscience Registered Nurse and practices in East Meadow, New York. Credentials: NP.
How much does Marijean Buhse, NP prescribe under Medicare Part D? ▼
In 2023, Marijean Buhse, NP wrote 517 Medicare Part D claims totaling $878K in drug costs for 93 beneficiaries.
What is Marijean Buhse, NP's Medicare quality score? ▼
Marijean Buhse, NP has a CMS MIPS Final Score of 84.5/100 (Quality: 93.3, Cost: 54.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Marijean Buhse, NP located? ▼
Marijean Buhse, NP is located at 801 MERRICK AVE, East Meadow, NY, 11554. Phone: (516) 393-8936.
What is Marijean Buhse, NP's NPI number? ▼
Marijean Buhse, NP's National Provider Identifier (NPI) is 1720091556, issued on 08/14/2006.
Does Marijean Buhse, NP prescribe more brand-name or generic drugs? ▼
Marijean Buhse, NP's prescribing is 15% brand-name and 85% generic drugs by claim count, with $835K in brand drug costs.
How many Neuroscience Registered Nurse providers are there in the US? ▼
There are 297 Neuroscience Registered Nurse providers across 43 states in the US. The average Neuroscience Registered Nurse provider writes 1,016 Medicare Part D claims per year.
What drugs does Marijean Buhse, NP prescribe most often? ▼
Based on 2023 Medicare Part D data, Marijean Buhse, NP's most frequently prescribed drugs include Baclofen, Gabapentin, Tizanidine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Marijean Buhse, NP accept Medicare? ▼
Marijean Buhse, NP appears in CMS Medicare data with 517 Part D claims and 93 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Marijean Buhse, NP's credentials? ▼
Marijean Buhse, NP's NPI is 1720091556 with credentials NP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.